Literature DB >> 29395085

Preservation of rat hearts in subfreezing temperature isochoric conditions to - 8 °C and 78 MPa.

Lili Wan1, Matthew J Powell-Palm2, Charles Lee3, Anshal Gupta2, Bradley P Weegman4, Mark G Clemens5, Boris Rubinsky2.   

Abstract

Isochoric (constant volume) preservation at subfreezing temperatures is being investigated as a novel method for preserving cells and organs. This study is a first initial effort to evaluate the efficacy of this method for heart preservation, and to provide a preliminary outline of appropriate preservation parameters. To establish a baseline for further studies, rat hearts were preserved in a University of Wisconsin (UW) intracellular solution for one hour under isochoric conditions at: 0 °C (atmospheric pressure - 0.1 MPa), - 4 °C (41 MPa), - 6 °C (60 MPa) and - 8 °C (78 MPa). The viability of the heart was evaluated using Langendorff perfusion and histological examination. The physiological performance of hearts preserved at - 4 °C (41 MPa) was comparable to that of a heart preserved on ice at atmospheric pressure, with no statistically significant difference in histological injury score. However, hearts preserved at -4 °C displayed substantially reduced interstitial edema compared to hearts preserved by conventional hypothermic preservation in UW on ice at atmospheric pressure, suggesting significant protection from increased vascular permeability following preservation. Hearts preserved at - 6 °C (60 MPa) suffered injury from cellular swelling and extensive edema, and at - 8 °C (78 MPa) hearts experienced significant morphological disruption. To the best of our knowledge, this is the first publication showing that a mammalian organ can survive low subfreezing temperatures without the use of a cryoprotective additive. Lowering the preservation temperature reduces metabolism and improves preservation quality, and these results suggest that improvements in preservation are possible at subzero temperatures with low to moderate pressures observed at -4 °C. Notably, tissue damage was observed at lower temperatures (-6 °C or below) accompanying further elevation of pressure associated with isochoric preservation that may prove detrimental. Therefore, subfreezing temperature isochoric preservation protocols should optimize, a combination of temperature and pressure that will minimize the negative effects of elevated pressure while retaining the beneficial effect of lower temperatures and reduced metabolism.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Cryopreservation; Isochoric system; Organ preservation

Mesh:

Substances:

Year:  2018        PMID: 29395085     DOI: 10.1016/j.bbrc.2018.01.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Foundations of modeling in cryobiology-III: Inward solidification of a ternary solution towards a permeable spherical cell in the dilute limit.

Authors:  Daniel M Anderson; James D Benson; Anthony J Kearsley
Journal:  Cryobiology       Date:  2019-10-08       Impact factor: 2.487

2.  Calculation of a temperature-volume phase diagram of water to inform the study of isochoric freezing down to cryogenic temperatures.

Authors:  Matthew J Powell-Palm
Journal:  RSC Adv       Date:  2022-07-17       Impact factor: 4.036

Review 3.  Foundations of modeling in cryobiology-II: Heat and mass transport in bulk and at cell membrane and ice-liquid interfaces.

Authors:  Daniel M Anderson; James D Benson; Anthony J Kearsley
Journal:  Cryobiology       Date:  2019-10-04       Impact factor: 2.487

Review 4.  Supercooling preservation technology in food and biological samples: a review focused on electric and magnetic field applications.

Authors:  Taiyoung Kang; Youngsang You; Soojin Jun
Journal:  Food Sci Biotechnol       Date:  2020-03-28       Impact factor: 2.391

5.  Thermo-mechanics aspects of isochoric cryopreservation: A new modeling approach and comparison with experimental data.

Authors:  Prem K Solanki; Yoed Rabin
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.